The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
Open accessAbstract
According to a recent hypothesis, venous thrombosis results from the concurrence of several factors. This hypothesis was assessed in patients with portal or hepatic venous thrombosis by simultaneously investigating most of the currently identified prothrombotic disorders, local precipitating factors, and other risk factors such as oral contraceptive use. Patients with a tumorous obstruction and patients with cirrhosis with portal vein thrombosis were excluded. The prothrombotic disorders that were investigated included classical and occult myeloproliferative disorders; antiphospholipid syndrome; protein C; protein S and antithrombin deficiency; factor V Leiden; factor II; and methylene-tetrahydrofolate-reductase gene mutations. We found 1 or several prothrombotic disorders and a local precipitating factor in 26 and 10 of the 36 patients with portal vein thrombosis, respectively; and in 28 and none of the 32 patients with hepatic vein thrombosis, respectively. We found a combination of prothrombotic disorders in 5 and 9 patients with portal and hepatic vein thrombosis, respectively, whereas such a combination is expected in less than 1% of asymptomatic subjects. Of the 10 patients with a local precipitating factor, 8 had a prothrombotic disorder. Of the 13 patients who use oral contraceptives, 10 had a prothrombotic disorder. We conclude that portal or hepatic venous thrombosis should be regarded as an index for 1 or several prothrombotic disorders, whether or not local precipitating factors or oral contraceptive use are found. Concurrence of prothrombotic disorders is more common than expected. Extensive investigation of prothrombotic disorders and anticoagulation should be considered in patients with portal or hepatic venous thrombosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値
Whittaker, P. G., Morgan, M. R., Dean, P., Cameron, E., & Lind, T. (1980) · The Lancet · Cited by 724
Hyperhomocysteinemia and Venous Thrombosis: A Meta-analysis
Heijer, M. D., Rosendaal, F., Blom, H., Gerrits, W., & Bos, G. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615380 · Cited by 378
Primary Myeloproliferative Disorder and Hepatic Vein Thrombosis
Valla, D. C., Casadevall, N., Lacombe, C., Varet, B. R., GOLDWASSER, E., FRANCO, D., MAILLARD, J.-N., PARIENTE, E. A., Leporrier, M., RUEFF, B., et al. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-3-329 · Cited by 299
Self-citationEtiology of portal vein thrombosis in adults
Valla, D., Casadevall, N., Huisse, M. G., Tulliez, M., Grange, J. D., Muller, O., Binda, T., Varet, B., Rueff, B., & Benhamou, J. P. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90567-7 · Cited by 247
Self-citationIncreased Risk for Venous Thrombosis in Carriers of the Prothrombin G→A20210 Gene Variant
Margaglione, M., Brancaccio, V., Giuliani, N., D'Andrea, G., Cappucci, G., Iannaccone, L., Vecchione, G., Grandone, E., & Di Minno, G. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00003 · Cited by 237
Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity
Rosner, E., Pauzner, R., Lusky, A., Modan, M., & Many, A. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651083 · Cited by 188
Stefano, V. D., Teofili, L., Leone, G. G. M., & Michiels, J. J. (1997) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-996117 · Cited by 152
Sonographic features of portal vein thrombosis
Gansbeke, D. V., Ef, A., Delcour, C., Engelholm, L., & Struyven, J. L. (1985) · American Journal of Roentgenology · doi:10.2214/ajr.144.4.749 · Cited by 143
Shrestha, S. M., Okuda, K., Uchida, T., Maharjan, K. G., Shrestha, S., JOSHI, B. L., LARSSON, S., & VAIDYA, Y. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00056.x · Cited by 140
Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.
Mahmoud, A. E., Elias, E., Beauchamp, N., & Wilde, J. (1997) · Gut · doi:10.1136/gut.40.6.798 · Cited by 137
Polycythemia Vera and the Myeloproliferative Disorders
Petitt, R. M. (1995) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63955-4 · Cited by 120
Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome
Pelletier, S., Landi, B., Pietté, J. C., Ekert, P., Coutellier, A., Desmoulins, C., Fadlallah, J.-P., Herson, S., & Valla, D. C. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80140-1 · Cited by 114
Self-citationFrequent factor II G20210A mutation in idiopathic portal vein thrombosis
Chamouard, P., Pencreach, E., Maloisel, F., Grunebaum, L., Ardizzone, J.-F., Meyer, A., Gaub, M., Goetz, J., Baumann, R., Uring‐Lambert, B., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70238-6 · Cited by 111
Hepatic venous outflow block caused by short-length hepatic vein stenoses
Valla, D. C., Hadengue, A., Younsi, M., Azar, N., Zeitoun, G., Boudet, M. C., Molas, G., Belghiti, J., Erlinger, S., Hay, J. M., et al. (1997) · Hepatology · doi:10.1002/hep.510250405 · Cited by 105
Self-citationHypercoagulable states: molecular genetics to clinical practice
SCHAFER, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92888-6 · Cited by 84
Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells
Schubert, J. E. A., Alvarado, M., Uciechowski, P., Zielinska‐Skowronek, M., Freund, M., Vogt, H., & Schmidt, R. E. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08060.x · Cited by 81
Disordered hemostasis in extrahepatic portal hypertension
Robson, S. C., Kahn, D., Kruskal, J. B., Bird, A. R., & Kirsch, R. E. (1993) · Hepatology · doi:10.1002/hep.1840180416 · Cited by 54
FORMES FRUSTES IN MYELOPROLIFERATIVE DISORDERS
Reid, C. D. L., Chanarin, I., & Lewis, J. D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92557-0 · Cited by 21
Resistance to activated protein C due to a factor V gene mutation
Zöller, B., Holm, J., & Dahlbäck, B. (1996) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(95)00130-1 · Cited by 18
Cited by
Vascular disorders of the liver # †
DeLeve, L. D., Valla, D.-C., & Garcia-Tsao, G. (2009) · Hepatology · doi:10.1002/hep.22772 · Cited by 978
Self-citationAASLD practice guidelines: Evaluation of the patient for liver transplantation†
Murray, K. F., & Carithers, R. L. (2005) · Hepatology · doi:10.1002/hep.20704 · Cited by 939
EASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study
Plessier, A., Darwish-Murad, S., Hernandez-Guerra, M., Consigny, Y., Fabris, F., Trebicka, J., Heller, J., Morard, I., Lasser, L., Langlet, P., et al. (2010) · Hepatology · doi:10.1002/hep.23259 · Cited by 597
Self-citationRisk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis
Amitrano, L., Anna Guardascione, M., Brancaccio, V., Margaglione, M., Manguso, F., Iannaccone, L., Grandone, E., & Balzano, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.001 · Cited by 582
Metadata
- Authors
- Denninger, M.-H., Chaït, Y., Casadevall, N., Hillaire, S., Guillin, M.-C., Bezeaud, A., Erlinger, S., Briere, J., & Valla, D.
- Venue
- Hepatology
- Published
- 2000-03
- Volume
- 31
- Issue
- 3
- Pages
- 587-591
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2029497230
- Cited by
- 686
- References
- 22
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.